Please login to the form below

Not currently logged in
Email:
Password:

Human Papilloma Virus

This page shows the latest Human Papilloma Virus news and features for those working in and with pharma, biotech and healthcare.

Conceiving the cervical cancer vaccine

Although not necessarily working directly against the cancer itself, cervical cancer vaccines protect against the human papilloma virus (HPV), which is thought to cause most cases of cervical cancer. ... The breakthrough of Prof Frazer and his team, who

Latest news

  • Cancer jab 'unlikely' to have caused death

    The injection is part of a national immunisation programme to protect girls against the two strains of human papilloma virus (HPV) that cause more than 70 per cent of cervical cancer

  • Boots pilots cervical cancer vaccine

    The vaccination helps protect against the most common cancer-causing types of Human Papilloma Virus (HPV), but it does not protect against all the cancer-causing viruses, so women will still

  • R&D news in brief

    Advance in search for cervical cancer vaccine. Scientists have made ground in the search for a cervical cancer vaccine by unravelling the body's immune response to the virus. ... A study by the University of Birmingham, published in the British Journal

  • Quantum leap

    cancer. Results published on October 6 suggest that the vaccine, Gardasil, administered in three doses over six months was 100 per cent successful at protecting against two types of human papilloma ... virus (HPV), which are present in 70 per cent of

  • New cervical cancer vaccine on trial

    The Queensland scientist behind the technology, former Australian of the Year Professor Ian Frazer, said the vaccine had exciting potential to offer protection from more strains of the sexually-transmitted human ... papilloma virus (HPV).

More from news
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Immunisation politicised Immunisation politicised

    Immunisation politicised. The case of Human Papilloma Virus. 2006 and 2007 saw the first worldwide approvals of vaccines designed to immunise women and girls in particular against certain strains of the ... sexually transmitted human papilloma virus (HPV)

  • Pharma deals in August 2015 Pharma deals in August 2015

    This was the fifth deal announced by AstraZeneca/Medimmune in the month under which the company gained access to INO-3112 a cancer vaccine which targets cancers caused by human papilloma ... Exclusive commercial licence. 165. Cytos Biotechnology.

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Understanding the "Big Picture"

    A good example of this “ Risk-awareness thinking” would be the impact of the cervical cancer vaccine to address human papilloma virus (HPV).

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics